Evidence map›Paper›PMID 28366503›Full record

Observational studyOphthalmology2017

Benign Yellow Dot Maculopathy: A New Macular Phenotype.

Arundhati Dev Borman, Aleksandra Rachitskaya, Martina Suzani, Robert A Sisk, Zubair M Ahmed, Graham E Holder, Valentina Cipriani, Gavin Arno, Andrew R Webster, Robert B Hufnagel and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Unilateral benign yellow dot maculopathy.American journal of ophthalmology case reports · 2021
    Article
  5. Benign yellow dot maculopathy.American journal of ophthalmology case reports · 2018
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Arundhati Dev BormanMoorfields Eye Hospital NHS Foundation Trust, London, United Kingdom; UCL Institute of Ophthalmology, London, United Kingdom. Electronic address: a.dev-borman@ucl.ac.uk.
Aleksandra RachitskayaBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
Martina SuzaniMoorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Robert A SiskCincinnati Eye Institute, University of Cincinnati Department of Ophthalmology, Abrahamson Pediatric Eye Institute, Cincinnati Children's Hospital, Cincinnati, Ohio.
Zubair M AhmedOtorhinolaryngology Head & Neck Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Graham E HolderMoorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Valentina CiprianiMoorfields Eye Hospital NHS Foundation Trust, London, United Kingdom; UCL Institute of Ophthalmology, London, United Kingdom; UCL Genetics Institute, London, United Kingdom.
Gavin ArnoMoorfields Eye Hospital NHS Foundation Trust, London, United Kingdom; UCL Institute of Ophthalmology, London, United Kingdom.
Andrew R WebsterMoorfields Eye Hospital NHS Foundation Trust, London, United Kingdom; UCL Institute of Ophthalmology, London, United Kingdom.
Robert B HufnagelOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Audina BerrocalBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
Anthony T MooreMoorfields Eye Hospital NHS Foundation Trust, London, United Kingdom; UCL Institute of Ophthalmology, London, United Kingdom; Ophthalmology Department, University of California San Francisco, San Francisco, California.
Moorfields Eye Hospital NHS Foundation Trust · GBUniversity of Miami · USCincinnati Children's Hospital Medical Center · USNational Institutes of Health · USUniversity of Maryland, Baltimore · US

Funding

Usher Proteins in the Inner Ear Structure and FunctionR01DC012564 · NIDCD · UNIVERSITY OF MARYLAND BALTIMORE · PI Zubair M. Ahmed, Gregory I Frolenkov · 2013 to 2026
$7.0M
Intramural NIH HHS Z99 EY999999NIDCD NIH HHS R01 DC012564
6 · The paper itself

Abstract

purposeTo describe a novel macular phenotype that is associated with normal visual function.

designRetrospective, observational case series.

participantsThirty-six affected individuals from 23 unrelated families.

methodsThis was a retrospective study of patients who had a characteristic macular phenotype. Subjects underwent a full ocular examination, electrophysiologic studies, spectral-domain optical coherence tomography (OCT), and fundus autofluorescence imaging. Genomic analyses were performed using haplotype sharing analysis and whole-exome sequencing.

main outcome measuresVisual acuity, retinal features, electroretinography, and whole-exome sequencing.

resultsTwenty-six of 36 subjects were female. The median age of subjects at presentation was 15 years (range, 5-59 years). The majority of subjects were asymptomatic and presented after a routine eye examination (22/36 subjects) or after screening because of a positive family history (13/36 subjects) or by another ophthalmologist (1/36 subjects). Of the 3 symptomatic subjects, 2 had reduced visual acuity secondary to nonorganic visual loss and bilateral ametropic amblyopia with strabismus. Visual acuity was 0.18 logarithm of the minimum angle of resolution (logMAR) or better in 30 of 33 subjects. Color vision was normal in all subjects tested, except for the subject with nonorganic visual loss. All subjects had bilateral symmetric multiple yellow dots at the macula. In the majority of subjects, these were evenly distributed throughout the fovea, but in 9 subjects they were concentrated in the nasal parafoveal area. The dots were hyperautofluorescent on fundus autofluorescence imaging. The OCT imaging was generally normal, but in 6 subjects subtle irregularities at the inner segment ellipsoid band were seen. Electrophysiologic studies identified normal macular function in 17 of 19 subjects and normal full-field retinal function in all subjects. Whole-exome analysis across 3 unrelated families found no pathogenic variants in known macular dystrophy genes. Haplotype sharing analysis in 1 family excluded linkage with the North Carolina macular dystrophy (MCDR1) locus.

conclusionsA new retinal phenotype is described, which is characterized by bilateral multiple early-onset yellow dots at the macula. Visual function is normal, and the condition is nonprogressive. In familial cases, the phenotype seems to be inherited in an autosomal dominant manner, but a causative gene is yet to be ascertained.

Indexed as

MutationVisual AcuityAdolescentAdultChildChild, PreschoolDNA Mutational AnalysisElectroretinographyExomeEye ProteinsFemaleFluorescein AngiographyFollow-Up StudiesFundus OculiHumansMacula LuteaEye Proteins

Identifiers

PMID28366503
PMCPMC5503697
OpenAlexW2598219270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.